News & Articles

Enabling new synthetic biology applications including protein production and the engineering of bacteria

Collaboration aims to aid in the distribution of next-generation sequencing and PCR testing kits for 2019-nCoV

Acquisition adds platform in gene variant interpretation based on next generation sequencing

SEQuoia Complete Stranded RNA Library Prep Kit is designed to be a novel approach to RNA-Seq library preparation

Single Technologies aims to deliver a paradigm shift in biomolecular analysis with Theta platform

Gain expert advice to help you succeed in NGS assay automation and minimize variability upfront

Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies

Abbott is making this new strain accessible to the research community to evaluate its impact on diagnostics, treatment and potential vaccines

Paragon Genomics announced the two products at the 2019 Association for Molecular Pathology (AMP)

Watch this webinar to find out how to automate your NGS workflow for cancer diagnostics and personalized medicine

The Sentosa® SQ HIV-1 Genotyping Assay is the first FDA De Novo-designated NGS assay for detecting HIV-1 drug resistance mutations

New kit from PerkinElmer shown to achieve over 90% correlation rate between biopsied embryos and testing spent culture media

Don't miss this week's webinar to find out how liquid handling can help automate your next-generation sequencing assays

Next-generation sequencing discovery pools enable larger custom panels and low sample numbers to speed up discovery

Grant received to use the Mission Bio Tapestri Platform to improve the measurement of residual cancerous cells remaining post-treatment

Discover the latest technologies and techniques that are revolutionizing quality control in the food industry

SelectScience is heading to Chicago, USA, to interview scientists at the forefront of neuroscience research and report on the latest techniques and technologies advancing the field

Trial successfully identifies people with advanced non-small cell lung cancer for treatment with Alecensa